US Patent Issued to OSPEDALE SAN RAFFAELE, IRBM, ISTITUTO NAZIONALE DI GENETICA MOLECOLARE-INGM on Nov. 11 for "Oxalamido-substituted tricyclic inhibitors of hepatitis b virus" (Italian Inventors)

Posted On: 2025-11-11

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,590, issued on Nov. 11, was assigned to OSPEDALE SAN RAFFAELE S.R.L. (Milan), IRBM S.P.A. (Pomezia, Italy) and ISTITUTO NAZIONALE DI GENETICA MOLECOLARE-INGM (Milan).

"Oxalamido-substituted tricyclic inhibitors of hepatitis b virus" was invented by Raffaele De Francesco (Milan), Lorena Donnici (Milan), Luca Guidotti (Milan), Matteo Iannacone (Milan), Romano Di Fabio (Pomezia, Italy), Vincenzo Summa (Pomezia, Italy), Adolfo Prandi (Milan), Pietro Randazzo (Milan), Leda Ivanova Bencheva (Milan), Marilenia De Matteo (Milan), Luca Ferrante (Milan), Davide Gornati (Milan) and Alessandro Grillo (Milan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The pre...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

US Patent Issued to OSPEDALE SAN RAFFAELE, IRBM, ISTITUTO NAZIONALE DI GENETICA MOLECOLARE-INGM on Nov. 11 for "Oxalamido-substituted tricyclic inhibitors of hepatitis b virus" (Italian Inventors)